Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by Hankerchiefon Nov 20, 2019 4:16pm

172 Views

Post# 30375570

RE:RE:RE:Lamm Protocol Blockbuster news

Gooseybear wrote: Thanks for the information Claridge but I don't need to be reminded of the 15 BCG treatments and several TURBT and cystoscopies I have been through that follow the Lamm protocol.

I feel for ya Goosey. There has to be a better way. Maybe something that involves on ly 1 or 2 treatments and be done with it? Hoping.

Bullboard Posts

How one company is disrupting PoC testing